BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

889 related articles for article (PubMed ID: 24387952)

  • 1. [Autoantibody profile in myositis].
    Allenbach Y; Benveniste O
    Rev Med Interne; 2014 Jul; 35(7):437-43. PubMed ID: 24387952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of autoantibodies for the diagnosis of autoimmune myopathies].
    Allenbach Y; Benveniste O
    Rev Neurol (Paris); 2013; 169(8-9):656-62. PubMed ID: 23642286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myositis-specific autoantibodies].
    Fujimoto M
    Brain Nerve; 2013 Apr; 65(4):449-60. PubMed ID: 23568993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
    Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
    JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
    Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management.
    Basharat P; Christopher-Stine L
    Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].
    Sibilia J; Chatelus E; Meyer A; Gottenberg JE; Sordet C; Goetz J
    Presse Med; 2010 Oct; 39(10):1010-25. PubMed ID: 20655695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New insights of myositis-specific and -associated autoantibodies in juvenile and adult type myositis].
    Váncsa A; Dankó K
    Orv Hetil; 2016 Jul; 157(30):1179-84. PubMed ID: 27452067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of Idiopathic Inflammatory Myopathy: A Muscle Pathology Perspective].
    Inoue M; Nishino I
    Brain Nerve; 2016 Dec; 68(12):1431-1441. PubMed ID: 27916753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Necrotizing myopathies: From genetic to acquired forms].
    Salort-Campana E; De Paula AM; Figarella-Branger D; Pouget J
    Rev Med Interne; 2014 Jul; 35(7):430-6. PubMed ID: 24359726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myositis: From classification to diagnosis].
    Fer F; Allenbach Y; Benveniste O
    Rev Med Interne; 2021 Jun; 42(6):392-400. PubMed ID: 33248855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies.
    Li S; Ge Y; Yang H; Wang T; Zheng X; Peng Q; Lu X; Wang G
    Clin Rheumatol; 2019 Aug; 38(8):2171-2179. PubMed ID: 30863950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acquired inflammatory myopathies: interest of specific autoantibodies for their classification].
    Benveniste O
    Rev Prat; 2015 May; 65(5):607-12. PubMed ID: 26165090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Utility of Auto-Antibodies in Inflammatory Muscle Diseases.
    Allenbach Y; Benveniste O
    J Neuromuscul Dis; 2015; 2(1):13-25. PubMed ID: 28198709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
    Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
    Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
    Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups.
    Love LA; Leff RL; Fraser DD; Targoff IN; Dalakas M; Plotz PH; Miller FW
    Medicine (Baltimore); 1991 Nov; 70(6):360-74. PubMed ID: 1659647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in adult patients with idiopathic inflammatory myopathies in Buenos Aires.
    Gómez GN; Gargiulo Mde L; Pérez N; Collado MV; Suárez LV; Khoury M; Sarano JF
    Medicina (B Aires); 2016; 76(3):129-34. PubMed ID: 27295700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.